Conor McNamara
Stock Analyst at RBC Capital
(1.91)
# 3,223
Out of 5,138 analysts
141
Total ratings
36.89%
Success rate
-8.95%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $68.67 | +6.31% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.92 | +27.55% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $231.25 | +10.27% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.90 | +57.89% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $102.43 | -55.09% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $74.98 | +16.03% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $12.16 | +39.80% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $141.65 | -11.05% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $313.53 | +30.45% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $323.10 | +26.59% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $162.02 | +25.91% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $618.72 | +2.95% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $235.99 | +5.94% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $33.20 | +83.73% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $5.45 | +28.44% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $68.67
Upside: +6.31%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.92
Upside: +27.55%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $231.25
Upside: +10.27%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.90
Upside: +57.89%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $102.43
Upside: -55.09%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $74.98
Upside: +16.03%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $12.16
Upside: +39.80%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $141.65
Upside: -11.05%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $313.53
Upside: +30.45%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $323.10
Upside: +26.59%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $162.02
Upside: +25.91%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $618.72
Upside: +2.95%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $235.99
Upside: +5.94%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $33.20
Upside: +83.73%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $5.45
Upside: +28.44%